Trials / Unknown
UnknownNCT04887012
Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To study the safety and effectiveness of HLA haploidentical CAR-NK cells targeting CD19 in patients with B-cell non-Hodgkin's lymphoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | anti-CD19 CAR-NK | lentiviral vector-transducted HLA haploidentical NK cells to express anti-CD19 CAR |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2022-05-01
- Completion
- 2024-05-01
- First posted
- 2021-05-14
- Last updated
- 2021-05-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04887012. Inclusion in this directory is not an endorsement.